![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1629592
¾Ö¿Ïµ¿¹° °Ç°Áø´Ü ½ÃÀå : Á¦Ç° À¯Çüº°, µ¿¹° À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, ¿ëµµº°, Áö¿ªº°Pet Health Screening Market, By Product Type, By Animal Type, By End User, By Application Disease Screening, Genetic Trait Testing, Allergy Testing, Routine Health Check, Weight and Nutrition Management, and Others), By Geography |
¼¼°èÀÇ ¾Ö¿Ïµ¿¹° °Ç°Áø´Ü ½ÃÀåÀº 2024³â¿¡´Â 25¾ï 2,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2031³â¿¡´Â 38¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2024-2031³â CAGRÀº 6.1%ÀÔ´Ï´Ù.
¸®Æ÷Æ® ¹üÀ§ | ¸®Æ÷Æ® »ó¼¼ | ||
---|---|---|---|
±âÁسâ | 2023³â | 2024³â ½ÃÀå ±Ô¸ð | 25¾ï 2,000¸¸ ´Þ·¯ |
½ÇÀû µ¥ÀÌÅÍ | 2019-2023³â | ¿¹Ãø ±â°£ | 2024-2031³â |
¿¹Ãø ±â°£ÀÎ 2024-2031³â CAGR : | 6.10% | 2031³â °¡Ä¡ ¿¹Ãø | 38¾ï 1,000¸¸ ´Þ·¯ |
¼¼°èÀÇ ¾Ö¿Ïµ¿¹° °Ç°Áø´Ü ½ÃÀåÀº ¾Ö¿Ïµ¿¹° »çÀ°·ü Áõ°¡¿Í ¹Ý·Áµ¿¹°ÀÇ °Ç°¿¡ ´ëÇÑ º¸È£ÀÚµéÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÃÖ±Ù ¼ö³â°£ °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ ¹Ý·Áµ¿¹° °Ç°°ËÁøÀº Áúº´À» Á¶±â¿¡ ¹ß°ßÇϰí Àû½Ã¿¡ Ä¡·áÇÒ ¼ö ÀÖµµ·Ï µµ¿Í ¹Ý·Áµ¿¹°ÀÇ »îÀÇ ÁúÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. °¡Ã³ºÐ ¼ÒµæÀÌ Áõ°¡ÇÏ°í ¹Ý·Áµ¿¹°ÀÇ Àΰ£È°¡ ÁøÇàµÊ¿¡ µû¶ó ¹Ý·Áµ¿¹° º¸È£ÀÚµéÀº ¹Ý·Áµ¿¹°ÀÇ ¿¹¹æÀû °Ç°°ü¸®¿¡ ´õ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±â¼úÀÇ ¹ßÀüÀ¸·Î ÇÑ ¹øÀÇ °Ë»ç·Î ¿©·¯ Áúº´À» Áø´ÜÇÒ ¼ö ÀÖ´Â Çõ½ÅÀûÀÎ Áø´Ü ÅøÀÌ °³¹ßµÇ¾î ¹Ý·Áµ¿¹° º¸È£ÀÚÀÇ Áø´ÜÀÌ ´õ¿í Æí¸®ÇØÁ³½À´Ï´Ù. ¹Ý·Áµ¿¹° °Ç° ÁöÃâ Áõ°¡¿Í °í±Þ °ËÁø ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ½ÃÀåÀº ¿¹Ãø ±â°£ Áß ¾ÈÁ¤ÀûÀÎ ¼Óµµ·Î °è¼Ó ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼¼°è ¾Ö¿Ïµ¿¹° °Ç°Áø´Ü ½ÃÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ¼±Áø±¹ÀÇ ¹Ý·Áµ¿¹° »çÀ°·ü Áõ°¡, ¹Ý·Áµ¿¹° ÇコÄɾ ´ëÇÑ ÁöÃâ Áõ°¡, ¼öÀÇ Áø´ÜÀÇ ¹ßÀü µîÀÌ ÀÖÀ¸¸ç, 2024³â 10¿ù ¹Ì±¹ ¼öÀÇ»çÇùȸ¿¡ µû¸£¸é ¹Ì±¹³» ¾à 8,500¸¸ °¡±¸°¡ ¹Ý·Áµ¿¹°À» Ű¿ì°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹Ý·Áµ¿¹° Àα¸ Áõ°¡´Â ´Ù¾çÇÑ °ËÁø ¹× Áø´Ü °Ë»ç¿¡ ´ëÇÑ ¾ÈÁ¤ÀûÀÎ ¼ö¿ä¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ Áß¿äÇÑ ÃËÁø¿äÀÎÀº Áúº´ Á¶±â ¹ß°ßÀÇ ÀÌÁ¡¿¡ ´ëÇÑ º¸È£ÀÚµéÀÇ ÀνÄÀÌ ³ô¾ÆÁø °ÍÀÔ´Ï´Ù. Çõ½ÅÀûÀÎ ´ÙÁß Áúȯ Áø´Ü °Ë»ç°¡ Ãâ½ÃµÇ¸é¼ ½ÃÀå ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ƯÁ¤ °í±Þ Áø´Ü ÀýÂ÷¿Í °ü·ÃµÈ ³ôÀº ºñ¿ëÀº ½ÃÀå È®´ë¸¦ ¾î´À Á¤µµ ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¹Ý¸é, º¸´Ù Àú·ÅÇÑ ¹Ý·Áµ¿¹° °ËÁø ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¿¬±¸°³¹ßÀÌ ÁøÇàµÇ°í ÀÖÀ¸¸ç, ÇâÈÄ ¼ö³â°£ ½ÃÀå ÁøÃâ±â¾÷¿¡°Ô Å« ±âȸ°¡ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÌ ¸®Æ÷Æ®´Â ¼¼°èÀÇ ¾Ö¿Ïµ¿¹° °Ç°Áø´Ü ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®Çϰí 2023³âÀ» ±âÁسâÀ¸·Î ÇÑ ¿¹Ãø ±â°£(2024-2031³â)ÀÇ ½ÃÀå ±Ô¸ð ¹× ¿¬Æò±Õ ¼ºÀå·ü(CAGR%)À» Á¦°øÇϰí ÀÖ½À´Ï´Ù.
¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¸ÅÃâ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °í·Á»çÇ×µµ Á¦°øÇÕ´Ï´Ù.
±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú ¹× Àü·«°ú °°Àº ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ¾Ö¿Ïµ¿¹° °Ç°Áø´Ü ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
º» Á¶»çÀÇ ´ë»óÀÌ µÇ´Â ÁÖ¿ä ±â¾÷¿¡´Â Zoetis Inc., IDEXX Laboratories Inc., Mars Petcare, Boehringer Ingelheim, Elanco Animal Health, Merck Animal Health, Ceva Sante Animale, Virbac, Neogen Corporation, PetIQ, Vetoquinol S.A., Heska Corporation, Abaxis, Inc., Antech Diagnostics, Trupanion, Inc. µîÀÌ ÀÖ½À´Ï´Ù.
ÀÌÇØ°ü°èÀÚ´Â ¼¼°èÀÇ ¾Ö¿Ïµ¿¹° °Ç°Áø´Ü ½ÃÀåÀÇ ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.
The global pet health screening market is estimated to be valued at USD 2.52 Bn in 2024 and is expected to reach USD 3.81 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.1% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | US$ 2.52 Bn |
Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
Forecast Period 2024 to 2031 CAGR: | 6.10% | 2031 Value Projection: | US$ 3.81 Bn |
The global pet health screening market has been witnessing significant growth in the recent past owing to rising pet adoption and increasing awareness about pet wellness among pet owners. Various pet health screening tests help detect diseases at an early stage and enable timely treatment, thereby improving the quality of life for pets. Rising disposable incomes and growing humanization of pets have prompted owners to invest more in preventive healthcare for their pets. Furthermore, technological advancements have enabled the development of innovative diagnostic tools that can screen for multiple diseases with just one test, making screening more convenient for pet owners. The market is expected to continue growing at a steady pace over the forecast period driven by increasing pet health expenditure and growing demand for advanced diagnostic solutions.
The key drivers propelling the global pet health screening market include rising pet adoption in developed nations, growing expenditure on pet healthcare, and advancements in veterinary diagnostics. In October 2024, according to American Veterinary Medical Association, around 85 million American households own a pet. This growing pet population base is creating steady demand for various screening and diagnostic tests. Another important growth driver is the increasing awareness among owners regarding early disease detection benefits. Availability of innovative multi-disease screening tests is also spurring market growth. However, high costs associated with certain advanced diagnostic procedures could hamper market expansion to some extent. On the upside, ongoing research & development towards more affordable pet screening solutions is expected to present significant opportunities for market participants over the coming years.
This report provides in-depth analysis of the global pet health screening market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pet health screening market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Zoetis Inc., IDEXX Laboratories Inc., Mars Petcare, Boehringer Ingelheim, Elanco Animal Health, Merck Animal Health, Ceva Sante Animale, Virbac, Neogen Corporation, PetIQ, Vetoquinol S.A., Heska Corporation, Abaxis, Inc., Antech Diagnostics, and Trupanion, Inc.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pet health screening market